Research progress of GPC3-targeted CAR-T immunotherapy in hepatocellular carcinoma
Hepatocellular carcinoma（HCC）is one of the most prevalent malignant tumors globally,characterized by its high degree of malignancy,challenging treatment options,and poor prognosis. Chimeric antigen receptor T cell（CAR-T）therapy,as an innovative therapeutic strategy,has advanced to the fifth generati...
Αποθηκεύτηκε σε:
| Κύριος συγγραφέας: | |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Chinês |
| Έκδοση: |
The Editorial Department of Chinese Journal of Clinical Research
2026-05-01
|
| Σειρά: | Zhongguo linchuang yanjiu |
| Θέματα: | |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|